Search for other papers by Annelies van’t Westeinde in
Google Scholar
PubMed
Search for other papers by Leif Karlsson in
Google Scholar
PubMed
Search for other papers by Valeria Messina in
Google Scholar
PubMed
Search for other papers by Lena Wallensteen in
Google Scholar
PubMed
Search for other papers by Manuela Brösamle in
Google Scholar
PubMed
Search for other papers by Giorgio Dal Maso in
Google Scholar
PubMed
Search for other papers by Alessandro Lazzerini in
Google Scholar
PubMed
Search for other papers by Jette Kristensen in
Google Scholar
PubMed
Search for other papers by Diana Kwast in
Google Scholar
PubMed
Search for other papers by Lea Tschaidse in
Google Scholar
PubMed
Search for other papers by Matthias K Auer in
Google Scholar
PubMed
Search for other papers by Hanna F Nowotny in
Google Scholar
PubMed
Department of Endocrine and Metabolic Diseases, Istituto Auxologico Italiano IRCCS, Milan, Italy
Search for other papers by Luca Persani in
Google Scholar
PubMed
Search for other papers by Nicole Reisch in
Google Scholar
PubMed
Search for other papers by Svetlana Lajic in
Google Scholar
PubMed
, which is required for the conversion of cholesterol to cortisol and aldosterone, rendering it either partly or completely ineffective ( 2 , 3 ). Patients with classic CAH, therefore, experience glucocorticoid (GC) and mineralocorticoid deficiency
Search for other papers by Marianna Viukari in
Google Scholar
PubMed
Search for other papers by Helena Leijon in
Google Scholar
PubMed
Search for other papers by Tiina Vesterinen in
Google Scholar
PubMed
Search for other papers by Sanni Söderlund in
Google Scholar
PubMed
Search for other papers by Päivi Hämäläinen in
Google Scholar
PubMed
Search for other papers by Iina Yliaska in
Google Scholar
PubMed
Search for other papers by Päivi Rautiainen in
Google Scholar
PubMed
Search for other papers by Reeta Rintamäki in
Google Scholar
PubMed
Search for other papers by Minna Soinio in
Google Scholar
PubMed
Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland
Search for other papers by Ilkka Pörsti in
Google Scholar
PubMed
Search for other papers by Pasi I Nevalainen in
Google Scholar
PubMed
Search for other papers by Niina Matikainen in
Google Scholar
PubMed
performed during continuous 50 µg/h cosyntropin infusion. Catheterization was considered successful when the selectivity index (SI = AV/inferior vena cava (IVC) cortisol concentrations) on both sides is ≥5. PA was classified as unilateral based on a
Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia
Search for other papers by Tomaž Kocjan in
Google Scholar
PubMed
University Rehabilitation Institute, Ljubljana, Slovenia
FAMNIT, University of Primorska, Koper, Slovenia
Search for other papers by Gaj Vidmar in
Google Scholar
PubMed
Clinical Institute of Radiology, University Medical Centre Ljubljana, Ljubljana, Slovenia
Search for other papers by Peter Popović in
Google Scholar
PubMed
Clinical Institute of Radiology, University Medical Centre Ljubljana, Ljubljana, Slovenia
Search for other papers by Milenko Stanković in
Google Scholar
PubMed
selectivity index (SI), determined as the ratio of concentrations of cortisol from an adrenal vein and the infra-adrenal inferior vena cava (IVC), was at least 5 on both sides ( 28 , 29 ). Lateralization index (LI) was calculated as the gradient of the higher
Search for other papers by Rachel Forfar in
Google Scholar
PubMed
Search for other papers by Mashal Hussain in
Google Scholar
PubMed
Search for other papers by Puneet Khurana in
Google Scholar
PubMed
Search for other papers by Jennifer Cook in
Google Scholar
PubMed
Search for other papers by Steve Lewis in
Google Scholar
PubMed
Search for other papers by Dillon Popat in
Google Scholar
PubMed
Search for other papers by David Jackson in
Google Scholar
PubMed
Search for other papers by Ed McIver in
Google Scholar
PubMed
Search for other papers by Jeff Jerman in
Google Scholar
PubMed
Search for other papers by Debra Taylor in
Google Scholar
PubMed
Search for other papers by Adrian JL Clark in
Google Scholar
PubMed
Search for other papers by Li F Chan in
Google Scholar
PubMed
vasopressin. ACTH then acts on the adrenal glands to produce glucocorticoids and cortisol in humans. Cortisol negatively feeds back at the level of the pituitary gland and hypothalamus to inhibit further production and release ACTH. The melanocortins act
Search for other papers by Sriharsha Gunna in
Google Scholar
PubMed
Search for other papers by Mahaveer Singh in
Google Scholar
PubMed
Search for other papers by Rakesh Pandey in
Google Scholar
PubMed
Search for other papers by Rungmei S K Marak in
Google Scholar
PubMed
Search for other papers by Amita Aggarwal in
Google Scholar
PubMed
Search for other papers by Bibhuti Mohanta in
Google Scholar
PubMed
Search for other papers by Liping Yu in
Google Scholar
PubMed
Search for other papers by Eesh Bhatia in
Google Scholar
PubMed
Primary adrenal insufficiency (PAI) or Addison’s disease is an uncommon disorder resulting from deficiency of cortisol and aldosterone due to the destruction of adrenal cortices ( 1 , 2 ). Early diagnosis and prompt institution of treatment is
Search for other papers by Natacha Driessens in
Google Scholar
PubMed
Search for other papers by Madhu Prasai in
Google Scholar
PubMed
Search for other papers by Orsalia Alexopoulou in
Google Scholar
PubMed
Search for other papers by Christophe De Block in
Google Scholar
PubMed
Search for other papers by Eva Van Caenegem in
Google Scholar
PubMed
Search for other papers by Guy T’Sjoen in
Google Scholar
PubMed
Search for other papers by Frank Nobels in
Google Scholar
PubMed
Search for other papers by Christophe Ghys in
Google Scholar
PubMed
Search for other papers by Laurent Vroonen in
Google Scholar
PubMed
Search for other papers by Corinne Jonas in
Google Scholar
PubMed
Search for other papers by Bernard Corvilain in
Google Scholar
PubMed
Search for other papers by Dominique Maiter in
Google Scholar
PubMed
criteria: (i) a simultaneous serum level cortisol below and a plasma ACTH 2-fold above reference ranges; (ii) a high plasma ACTH concentration with a failed cortisol response (<400 nmol/L) to 250 µg intravenous ACTH injection and/or (iii) chronic treatment
National Institute of Endocrinology CI Parhon, Bucharest, Romania
Search for other papers by Sofia Maria Lider Burciulescu in
Google Scholar
PubMed
National Institute of Endocrinology CI Parhon, Bucharest, Romania
Search for other papers by Monica Livia Gheorghiu in
Google Scholar
PubMed
Search for other papers by Andrei Muresan in
Google Scholar
PubMed
National Institute of Endocrinology CI Parhon, Bucharest, Romania
Search for other papers by Iuliana Gherlan in
Google Scholar
PubMed
Search for other papers by Attila Patocs in
Google Scholar
PubMed
National Institute of Endocrinology CI Parhon, Bucharest, Romania
Search for other papers by Corin Badiu in
Google Scholar
PubMed
metastatic disease were CT scans and MRIs. The presence of AI was defined as low morning (08:00–09.00 h) cortisol level (<3 µg/dL) and insufficient cortisol response to a stimulation (Synachten) test at a maximum 1 month post surgery and the need of gluco
Search for other papers by Paola Parra Ramírez in
Google Scholar
PubMed
Search for other papers by Patricia Martín Rojas-Marcos in
Google Scholar
PubMed
Medicine Department, Basque Country University, Bilbao, Spain
Search for other papers by Miguel Paja Fano in
Google Scholar
PubMed
Search for other papers by Marga González Boillos in
Google Scholar
PubMed
Instituto de Investigación Biomédica Ramón y Cajal (IRYCIS), Madrid, Spain
Search for other papers by Eider Pascual-Corrales in
Google Scholar
PubMed
Search for other papers by Ana García-Cano in
Google Scholar
PubMed
Search for other papers by Jorge Gabriel Ruiz-Sanchez in
Google Scholar
PubMed
Search for other papers by Almudena Vicente in
Google Scholar
PubMed
Search for other papers by Emilia Gómez-Hoyos in
Google Scholar
PubMed
Search for other papers by Rui Ferreira in
Google Scholar
PubMed
Search for other papers by Iñigo García Sanz in
Google Scholar
PubMed
Search for other papers by Mònica Recasens in
Google Scholar
PubMed
Search for other papers by Begoña Pla Peris in
Google Scholar
PubMed
Search for other papers by Rebeca Barahona San Millan in
Google Scholar
PubMed
CIBEROBN, Madrid, Spain
Search for other papers by María José Picón César in
Google Scholar
PubMed
Search for other papers by Patricia Díaz Guardiola in
Google Scholar
PubMed
Search for other papers by Juan Jesús García González in
Google Scholar
PubMed
Search for other papers by Carolina Perdomo in
Google Scholar
PubMed
Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Oviedo, Spain
Search for other papers by Laura Manjón in
Google Scholar
PubMed
Search for other papers by Rogelio García-Centeno in
Google Scholar
PubMed
Search for other papers by Juan Carlos Percovich in
Google Scholar
PubMed
Search for other papers by Ángel Rebollo Román in
Google Scholar
PubMed
Search for other papers by Paola Gracia Gimeno in
Google Scholar
PubMed
Search for other papers by Cristina Robles Lázaro in
Google Scholar
PubMed
Search for other papers by Manuel Morales in
Google Scholar
PubMed
Search for other papers by Felicia Hanzu in
Google Scholar
PubMed
Instituto de Investigación Biomédica Ramón y Cajal (IRYCIS), Madrid, Spain
University of Alcalá, Madrid, Spain
Search for other papers by Marta Araujo-Castro in
Google Scholar
PubMed
) in whom PA (normal plasma aldosterone (PAC)/renin ratio) and glucocorticoid excess (cortisol post-dexamethasone suppression test <1.8 µg/dL) was excluded, were included as control groups. Two control groups were established: one group <65 years old
Division of Endocrinology and Metabolism, Department of Pediatrics, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand
Search for other papers by Supitcha Patjamontri in
Google Scholar
PubMed
NIHR Health Protection Research Unit on Chemical Radiation Threats and Hazards, Imperial College London, London, UK
Search for other papers by Alexander Spiers in
Google Scholar
PubMed
NIHR Health Protection Research Unit on Chemical Radiation Threats and Hazards, Imperial College London, London, UK
National Institute for Health Research (NIHR) Health Protection Research Unit in Environmental Exposures and Health, Imperial College London, London, UK
Mohn Centre for Children’s Health and Wellbeing, Imperial College London, London, UK
Search for other papers by Rachel B Smith in
Google Scholar
PubMed
NIHR Health Protection Research Unit on Chemical Radiation Threats and Hazards, Imperial College London, London, UK
Search for other papers by Chen Shen in
Google Scholar
PubMed
Search for other papers by Jo Adaway in
Google Scholar
PubMed
Search for other papers by Brian G Keevil in
Google Scholar
PubMed
NIHR Health Protection Research Unit on Chemical Radiation Threats and Hazards, Imperial College London, London, UK
National Institute for Health Research (NIHR) Health Protection Research Unit in Environmental Exposures and Health, Imperial College London, London, UK
Mohn Centre for Children’s Health and Wellbeing, Imperial College London, London, UK
Search for other papers by Mireille B Toledano in
Google Scholar
PubMed
Search for other papers by S Faisal Ahmed in
Google Scholar
PubMed
Software 2021 98 1 – 27 . ( https://doi.org/10.18637/jss.v098.i11 ) 34 Harden KP Wrzus C Luong G Grotzinger A Bajbouj M Rauers A Wagner GG & Riediger M . Diurnal coupling between testosterone and cortisol from adolescence to older
Department of Analysis, Universidade Federal do Rio Grande do Sul (UFRGS), School of Pharmacy, Porto Alegre, RS, Brazil
Search for other papers by Simone Martins de Castro in
Google Scholar
PubMed
Search for other papers by Paloma Wiest in
Google Scholar
PubMed
Search for other papers by Poli Mara Spritzer in
Google Scholar
PubMed
Universidade Federal de Ciências da Saúde de Porto Alegre (UFCSPA), Porto Alegre, RS, Brazil
Department of Pediatrics, Universidade Federal do Rio Grande do Sul (UFRGS), Medical School, Porto Alegre, RS, Brazil
Search for other papers by Cristiane Kopacek in
Google Scholar
PubMed
Introduction Congenital adrenal hyperplasia (CAH) is an autosomal recessive disorder characterized by inadequate cortisol secretion (with or without insufficient aldosterone production) and androgen excess, caused by deficiency in one of the